© Federation of European Biochemical Societies
Edited By: Seamus Martin
Impact Factor: 4.001
ISI Journal Citation Reports © Ranking: 2014: 77/289 (Biochemistry & Molecular Biology)
Online ISSN: 1742-4658
New Members of the Editorial Board
New members of The FEBS Journal Editorial Board
We are very pleased to welcome five new members of the Editorial Board:
Andrey Abramov, London; Michael Boutros, Heidelberg; Eleonora Candi, Rome; Kevin Ryan, Glasgow, Commissioning Editor; and Andreas Villunger, Innsbruck
Andrey Y. Abramov, London
Michael Boutros, Heidelberg
Eleonora Candi, Rome
Dr Eleonora Candi received her Doctoral degree in Biology (1991) and her PhD (1995) from the University of Rome “Tor Vergata”, Italy, before becoming Associate Professor in Molecular Biology at the Faculty of Medicine at the University of Rome “Tor Vergata”. She did her pre- and post-doctoral training, from 1993–1998, at the Skin Biology Branch, NIAMS, National Institute of Health, Bethesda, MD, USA, working on transglutaminases and their substrates. She has been working on cell death, both apoptosis and cornification, for the past 18 years. Her current scientific interest is the role of p63, homolog of p53, in epithelia development and tumour formation.
Kevin Ryan, Glasgow (Commissioning Editor)
Professor Kevin Ryan obtained his BSc in Biochemistry from the University of Liverpool, and was awarded a PhD by the University of Glasgow for work at the Beatson Institute for Cancer Research. Following post-doctoral work at the US National Cancer Institute at Frederick, Maryland, he was granted a Cancer Research UK Senior Cancer Research Fellowship and returned to the Beatson to establish his own research group. In 2007, he was appointed Professor of Molecular Cell Biology at the University of Glasgow. He has been awarded the European Association for Cancer Research (EACR) ‘Cancer Researcher Award’ and the Tenovus Medal. Kevin’s studies focus on the identification of cell death regulators involved in tumour development and tumour therapy, with particular focus on how the apoptotic and autophagic pathways integrate to determine cell fate.
Andreas Villunger, Innsbruck
Professor Andreas Villunger conducted his undergraduate studies in Biology in Salzburg and Innsbruck, Austria, and obtained his Master and PhD degrees for research on cytokine signalling in multiple myeloma. After post-doctoral work in the Ras/PKC signalling field, Andreas moved to the Walter and Eliza Hall Institute, Melbourne, Australia, to conduct research on the role of Bcl-2 family proteins in lymphocyte development and transformation. After his return to Austria in 2003, he continued to work on Bcl-2 family proteins in the immune system and started to explore the role of caspases in tumor suppression. He has been awarded the prestigious START Prize by the Austrian Science Fund and the Novartis Prize for Medical Research. In 2009, he was appointed full professor at the Medical University Innsbruck and is head of the Division of Developmental Immunology.